FDA Approved: PROMETHEGAN — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Cosette Pharmaceuticals' PROMETHEGAN (promethazine hydrochloride), updating its labeling under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Motion Sickness
• Nausea and Vomiting
• Urticaria

Drugs mentioned

• PROMETHEGAN (PROMETHAZINE HYDROCHLORIDE)

Snippet

SUPPL AP for PROMETHEGAN (PROMETHAZINE HYDROCHLORIDE)